XPOF vs MNRO

For growth investors, Xponential Fitness, Inc.

(XPOF) is the stronger pick with -1. 7% revenue growth year-over-year, versus -6. 4% for Monro, Inc. (MNRO). Analysts rate Xponential Fitness, Inc. (XPOF) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Xponential Fitness, Inc.

(XPOF) delivered a total return of -46. 6%, compared to -67. 6% for Monro, Inc. (MNRO). Over 10 years, the gap is even starker: XPOF returned -46. 6% versus MNRO's -62. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Monro, Inc.

(MNRO) is the lower-risk stock at 1. 50β versus Xponential Fitness, Inc. 's 1. 94β — meaning XPOF is approximately 29% more volatile than MNRO relative to the S&P 500.

By revenue growth (latest reported year), Xponential Fitness, Inc.

(XPOF) is pulling ahead at -1. 7% versus -6. 4% for Monro, Inc. (MNRO). On earnings-per-share growth, the picture is similar: Xponential Fitness, Inc. grew EPS 35. 2% year-over-year, compared to -119. 3% for Monro, Inc.. Over a 3-year CAGR, XPOF leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Monro, Inc.

(MNRO) is the more profitable company, earning -0. 4% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps -0. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XPOF leads at 25. 3% versus 3. 4% for MNRO. At the gross margin level — before operating expenses — XPOF leads at 75. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Xponential Fitness, Inc.

(XPOF) trades at 10. 9x forward P/E versus 32. 4x for Monro, Inc. — 21. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MNRO: 129. 5% to $40. 00.

All stocks in this comparison pay dividends.

Monro, Inc. (MNRO) offers the highest yield at 6. 4%, versus 2. 5% for Xponential Fitness, Inc. (XPOF).

For long-horizon retirement investors, Monro, Inc.

(MNRO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6. 4% yield). Xponential Fitness, Inc. (XPOF) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MNRO: -62. 4%, XPOF: -46. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: XPOF is a small-cap quality compounder stock; MNRO is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.